UCHastings Instagram

Student-Alumni #BOB
Instagram Photo Likes chesc2015, cristalergy, liannemarcella and 24 others like this.
Friday, February 14, 2014

Patent Trolling: Why Bio & Pharmaceuticals Are at Risk

Groundbreaking study by Professor Robin Feldman and Harvard Fellow Dr. Nicholson Price show conventional wisdom is wrong when it comes to patent trolls, bio and pharma.
Sample alt tag.
Robin Feldman, Professor of Law and Director, Institute for Innovation Law

Conventional wisdom holds that bio and pharma are safe from patent trolls. In a ground-breaking study, Professor Robin Feldman and Harvard Fellow Dr. Nicholson Price show that the conventional wisdom is wrong.

The study is available for download via SSRN: Patent Trolling: Why Bio & Pharmaceuticals Are at Risk. Highlights include:

  • With the Association of University Technology Managers revisiting its policy against selling to NPEs, the authors considered whether universities could provide an extensive pool of ammunition for NPEs to launch against current products.
  • To supplement increasing anecdotal evidence that patent trolling is moving into bio and pharma, the authors examined the life science holdings of five major universities.We skimmed the patent holdings for four of the of five university systems with the highest number of patents issued in fiscal year 2011: the University of California system, the University of Texas system, MIT, and CalTech. We added as a wild-card the University of South Florida, the school among the top 10 in 2011 patent grants which had the lowest ratio of license revenues to research expenditures. 
  • The study identified dozens of patents that could be deployed against current bio and pharm industries, following the patterns that NPEs have used against other industries. These include patents on drug formulas, methods of treatments, research methods, dosage forms, and others.
  • In deciding whether to undertake the study, the authors agonized over whether the potential for harm outweighed the potential benefit. After all, if reform efforts are not undertaken, the work could simply provide a handy road map for those who would follow.
  • Life sciences trolling is predictable and in its infancy, however. The study is intended to sound a warning bell.

About the Instititute for Innovation Law at UC Hastings

The Institute for Innovation Law (Institute) is a public interest academic center at UC Hastings. The Institute engages in academic research and education to encourage innovation through the practice and development of law and policy. The Institute’s mission is to identify and promote the tools, knowledge, and skills needed to encourage innovation through the practice and development of law and policy.

Media Contact

Alex A.G. Shapiro
Director, Communications & Public Affairs
UC Hastings College of the Law
Office: (415) 581-8842
Cell: (415) 813-9214
Email: shapiroa@uchastings.edu

Go to News Archive

Share this Story

Share via Facebook
Share via TwitterShare via EmailPrint Friendly Version

Other Recent Stories/ RSS

Friday, February 27, 2015

Chancellor & Dean Emerita Mary Kay Kane Elected to Board of IALS

The International Association of Law Schools was founded in 2005 at the behest of legal educators who recognized the growing inter-relationship of norms from transnational legal systems.
Friday, February 27, 2015

Thinkers & Doers: February 27, 2015

UC Hastings community members in the news and making moves February 21, 2015 - February 27, 2015.
Wednesday, February 25, 2015

Regulating Assisted Living and Senior Real Estate

3L Gordon Chan and 2L Katelyn Phillips are working with the Consortium on research into two key policy issues facing vulnerable older adults in California.
Tuesday, February 24, 2015

How Law School Prepared 3L Hali Ford to Compete on Survivor

Q & A with 3L Hali Ford, who appears in the 30th season of Survivor, premiering on Wednesday Feb. 25 at 8 pm on CBS.
Monday, February 23, 2015

Why International Antitrust as a Potential Career?

Free lunchtime panel explores careers in protecting competition, busting cartels and halting price-fixing in international markets.
Go to News Archive